Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)
Middle East Pharmaceutical Industries Co. (Avalon Pharma) offered today, Jan. 30, as many as 600,000 shares for retail subscription at SAR 82 a share, as per the book-building process.
The company planned to offer six million shares, or 30% of its post-IPO capital of SAR 200 million (20 million shares).
The receiving banks are Saudi National Bank (SNB) and Alinma Bank.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}